.jpg)
tHEORetically Speaking
Insights, observations, and executive interviews that discuss data and evidence to guide value-based decisions in health care. For more, visit our blog: https://healtheconomics.com/theoretically-speaking/
Episodes
44 episodes
INsights & OUTcomes with Vernon Schabert
Welcome to INsights & OUTcomes, the newest podcast on tHEORetically Speaking from HealthEconomics.com, where we sit down with the leading professionals in HEOR, RWE, and market access, the experts shaping the future of healthcare decisio...
•
Season 4
•
Episode 4
•
32:11

INsights & OUTcomes with Rosa Willock
Welcome to INsights & OUTcomes, the newest podcast on tHEORetically Speaking from HealthEconomics.com, where we sit down with the leading professionals in HEOR, RWE, and market access, the experts shaping the future of healthcare decisio...
•
Season 4
•
Episode 3
•
19:02
.jpg)
INsights & OUTcomes with Chris O'Neill
Welcome to INsights & OUTcomes, the newest podcast on tHEORetically speaking from HealthEconomics.com, where we sit down with the leading professionals in HEOR, RWE, and market access, the experts shaping the future of healthcare decisio...
•
Season 4
•
Episode 2
•
30:49

INsights & OUTcomes - COMING SOON to tHEORetically Speaking
Join us for INsights & OUTcomes where we sit down with the leading professionals in HEOR, RWE & RWD, and Market Access, the experts shaping the future of healthcare decisions.We'll dive into their careers, their passions, and the...
•
Season 4
•
Episode 1
•
1:18

tHEORetically speaking: Making Real-World Data Research-Ready
This episode of tHEORetically Speaking features Jeffrey Brown, PhD and Matvey Palchuk, MD, MS, FAMIA of TriNetX, who discuss the rise of RWD and its role in revolutionizing healthcare research, and how the TriNetX team approaches data qualit...
•
Season 3
•
Episode 11
•
23:03
.jpg)
tHEORetically speaking: Between Two Scientists: Care During Pregnancy - How RWD Can Help Balance the Needs of Mom and Baby
This episode of tHEORetically Speaking is the fourth podcast in Panalgo’s ‘Between Two Scientists’, featuring host Meg Richards, PhD, MPH, who sits down with Panalgo’s VP of Medical Affairs, Dr. Mark Friedman, to discuss balancing the health...
•
Season 3
•
Episode 10
•
12:54
.jpg)
tHEORetically speaking: How AI-Powered Phenotyping Enhances the Patient Journey for Life Science Applications
In this episode of tHEORetically speaking, Dr. Joseph Zabinksi, VP and Head of Commercial Strategy and AI at OM1, explains how AI-powered digital phenotyping can enhance our understanding of patients' experiences and inform access, treatment...
•
Season 3
•
Episode 9
•
14:41
.jpg)
tHEORetically speaking: Clinical Outcomes Assessments and Training
In this episode of tHEORetically Speaking, join Kelly Lipman, Heather Dickerson, and Ryan Murphy from ICON, who answer questions from a recent webinar on the dynamic landscape of clinical outcomes assessments, examining their historical signifi...
•
Season 3
•
Episode 8
•
8:11
.jpg)
tHEORetically speaking: EU HTA Joint Clinical Assessments
In this episode of tHEORetically Speaking, join Dr. Rosemary Jose, Dr. Sonja Kroep, and Nick Halfpenny from OPEN Health, Dr. Ansgar Hebborn from Roche, and James Ryan from AstraZeneca, who answer questions from a recent webinar on several polic...
•
Season 3
•
Episode 7
•
13:07
.jpg)
tHEORetically speaking: Cell & Gene Therapies
In this episode of tHEORetically Speaking, join Dr. Pamela Landsman-Blumberg, Amanda O’Hora, and Ajay Keshava from Magnolia Market Access, who answer questions from a recent webinar on how early stage planning taking into account commercial pro...
•
Season 3
•
Episode 6
•
5:18
.jpg)
tHEORetically speaking: Patient-Centered Real-World Evidence in Rare Diseases
In this episode of tHEORetically Speaking, join Drs. Megan Gower and Edward Chou from Takeda, and Richard Tsai, MS from Inspire, who answer questions from a recent webinar on the challenges and solutions for generating patient-centered real-wor...
•
Season 3
•
Episode 5
•
15:10
.jpg)
tHEORetically speaking: Real-World Evidence Generation with Disease Registries
In this episode of tHEORetically Speaking, join Drs. Javier Cid, Nahila Justo, and Delphine Saragoussi from Evidera and PPD, who answer questions from a recent webinar on why strong connections with registry groups and stakeholder populations a...
•
Season 3
•
Episode 4
•
4:26
.jpg)
tHEORetically speaking: Clinical Outcome Assessment (COA) Translations
In this episode of tHEORetically speaking, join Christelle Giroudet, MA and Ana Alvarez, MA, COA Linguistic Validation Leaders with ICON, as they highlight the importance of Linguistic Validation and how equivalence should be a key focus during...
•
Season 3
•
Episode 3
•
22:09
.jpg)
tHEORetically speaking: Between Two Scientists - New Types of Data
This episode of tHEORetically Speaking is the third installment of Panalgo’s ‘Between Two Scientists’, featuring host Meg Richards, Executive Director of Solutions at Panalgo, who chats with Norstella’s General Manager of RWD, Ted Search, Ge...
•
Season 3
•
Episode 2
•
7:51
.jpg)
tHEORetically speaking: Total System Value™ - A DYNAMIC APPROACH TO VALUE DEMONSTRATION
HEOR Ltd. have been working on an exciting new framework called Total System Value™. This episode of tHEORetically speaking features their CEO Phil McEwan and CGO Jeff Anderson to talk to us about this dynamic approach to value demonstration...
•
Season 3
•
Episode 1
•
22:39
.jpg)
tHEORetically speaking: Between Two Scientists - Labeling and Certifying your Varietal Data Blend
This episode of tHEORetically Speaking is the second installment of Panalgo's 'Between Two Scientists', featuring host Meg Richards, Executive Director of Solutions at Panalgo, and Bobby Samuels, General Manager of Privacy Hub at Datavant.
•
Season 2
•
Episode 11
•
8:35

tHEORetically speaking: How AI Can Help Dermatology: Diagnosis, Treatment, Risk, and R&D
The hype around AI is finally translating into real-world value, and we are seeing broader adoption of real-world data in Dermatology. This episode of tHEORetically Speaking features Dr. Stefan Weiss, Managing Director of Dermatology and Dr. Jo...
•
Season 2
•
Episode 10
•
15:54

tHEORetically speaking: The Future of Diversity in Clinical Trials: Real-World Evidence
This episode of tHEORetically Speaking features real-world evidence experts Alexandrina Balanean, Parisa Asgarisabet, and Danielle Gentile from Cardinal Health discussing the problems caused by lack of diverse representation in clinical tria...
•
Season 2
•
Episode 9
•
8:56

tHEORetically speaking: Between Two Scientists - Data Linkage
This episode of tHEORetically Speaking features our host Meg Richards, Executive Director of Solutions at Panalgo, who will be speaking with Erik Maul, Senior Director of Data Partnerships at Panalgo about data linkage.The health...
•
Season 2
•
Episode 8
•
7:51

tHEORetically speaking: Detecting and Decoding Alzheimer's with Real-World Data
The landscape for Alzheimer's disease is rapidly changing. This episode of tHEORetically speaking features Dr. Carl Marci from OM1 and Dr. Luke Stoeckel from NIA, as they discuss the critical need for earlier detection leading to ...
•
Season 2
•
Episode 7
•
16:04

tHEORetically speaking: Leveraging Real-World Data for Precision Obesity Treatment
In this episode of tHEORetically speaking, Gary Curhan, Chief Medical Officer and Jessica Paulus, Vice President of Research at OM1, as they answer questions on Leveraging Real-World Data for Precision Obesity Treatment. For more inform...
•
Season 2
•
Episode 6
•
25:18

tHEORetically speaking: Medicare and Medicaid Services Market Pricing
In this episode of tHEORetically Speaking, join ICON experts Mark McCoy, Dr. Earlene Biggs, Bruce Capobianco, Dr. Tanja Obradovic, Ki Park, and Nancy Risebroughas they answer questions on the Centers for Medicare and Medicaid Services’ negotiat...
•
Season 2
•
Episode 5
•
5:21

tHEORetically speaking: Medicare Data for RWD Analysis
In this episode of tHEORetically Speaking, join Dr. Eunice Chang and Dr. Michael Broder from PHAR, and Mitra Corral from Genentechas they answer questions on the how and why use of Medicare data for conducting various types of RWD analysis is i...
•
Season 2
•
Episode 4
•
11:15

tHEORetically speaking: The Benefits of Linking SDOH Data with Other Real-World Data
In this episode of tHEORetically speaking, join Dr. Pamela Landsman-Blumberg from Magnolia Market Access and Dr. Rick Chapman from Innovation and Value Initiativeas they answer questions on the importance of social determinants of health (SDOH)...
•
Season 2
•
Episode 3
•
4:02

tHEORetically speaking: Improving the Representativeness of Research
In this episode of tHEORetically speaking, join Dr. Bruce Feinberg, Dr. Danielle Gentile, Dr. Parisa Asgarisabet, and Alexandrina Balanean from Cardinal Health as they answer questions on the economic impact and role of real world evidence (RWE...
•
Season 2
•
Episode 2
•
7:05
